157 related articles for article (PubMed ID: 38330619)
1. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer.
Jin Y; Jiang A; Sun L; Lu Y
BMC Cancer; 2024 Feb; 24(1):238. PubMed ID: 38383342
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
Cui H; Zhao J
J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
Qin Z; Zheng X; Fang Y
Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and Clinicopathological Correlation of Long Noncoding RNA TMPO-AS1 in Colorectal Cancer Patients.
Mohammadrezakhani H; Baradaran B; Shanehbandi D; Asadi M; Hashemzadeh S; Hajiasgharzadeh K; Safaralizadeh R
J Gastrointest Cancer; 2020 Sep; 51(3):952-956. PubMed ID: 31768869
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
Hu Y; Zhang Y; Ding M; Xu R
J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056
[TBL] [Abstract][Full Text] [Related]
9.
Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
11. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis.
Chang H; Yao Y
Bioengineered; 2022 Feb; 13(2):2889-2901. PubMed ID: 35040749
[TBL] [Abstract][Full Text] [Related]
12. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
13. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
[TBL] [Abstract][Full Text] [Related]
14. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
[TBL] [Abstract][Full Text] [Related]
15. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
Peng X; Yan J; Cheng F
Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1.
Liu X; Wang H; Tao GL; Chu TB; Wang YX; Liu L
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11006-11015. PubMed ID: 33215415
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TMPO-AS1 facilitates the progression of colorectal cancer cells via sponging miR-98-5p to upregulate BCAT1 expression.
Ye J; Yan Y; Xin L; Liu J; Tang T; Bao X
J Gastroenterol Hepatol; 2022 Jan; 37(1):144-153. PubMed ID: 34370878
[TBL] [Abstract][Full Text] [Related]
19. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
Yang J; Liang B; Hou S
J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914
[TBL] [Abstract][Full Text] [Related]
20. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.
Luo H; Yang L; Liu C; Wang X; Dong Q; Liu L; Wei Q
Int J Biochem Cell Biol; 2020 May; 122():105702. PubMed ID: 32087328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
